Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page
- CheckyesterdayChange DetectedSite revision updated from v3.5.0 to v3.5.2. There is no indication that study content or user-facing features on the page were altered.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.0 is now active, replacing v3.4.3. No user-facing content or study details are affected.SummaryDifference0.1%

- Check37 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedAn addition of Revision: v3.4.2 is displayed. The notice about government funding lapse and the reference to Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check73 days agoChange DetectedAdded a government funding lapse notice banner and updated the site revision to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedA glossary toggle was added and footer notes were updated to include No FEAR Act Data and Revision: v3.4.0, with minor wording changes (e.g., capitalization in 'Last Update Submitted that Met QC Criteria'). The study content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.